Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6BV3

Crystal structure of porcine aminopeptidase-N with Leucine

Summary for 6BV3
Entry DOI10.2210/pdb6bv3/pdb
Related PRD IDPRD_900017
DescriptorAminopeptidase N, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (8 entities in total)
Functional Keywordszinc aminopeptidase, hydrolase
Biological sourceSus scrofa (Pig)
Total number of polymer chains1
Total formula weight108817.15
Authors
Chen, L.,Lin, Y.-L.,Li, F. (deposition date: 2017-12-12, release date: 2018-01-17, Last modification date: 2024-11-20)
Primary citationJoshi, S.,Chen, L.,Winter, M.B.,Lin, Y.L.,Yang, Y.,Shapovalova, M.,Smith, P.M.,Liu, C.,Li, F.,LeBeau, A.M.
The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach.
Sci Rep, 7:1424-, 2017
Cited by
PubMed Abstract: The M1 family of metalloproteases represents a large number of exopeptidases that cleave single amino acid residues from the N-terminus of peptide substrates. One member of this family that has been well studied is aminopeptidase N (APN), a multifunctional protease known to cleave biologically active peptides and aide in coronavirus entry. The proteolytic activity of APN promotes cancer angiogenesis and metastasis making it an important target for cancer therapy. To understand the substrate specificity of APN for the development of targeted inhibitors, we used a global substrate profiling method to determine the P1-P4' amino acid preferences. The key structural features of the APN pharmacophore required for substrate recognition were elucidated by x-ray crystallography. By combining these substrate profiling and structural data, we were able to design a selective peptide inhibitor of APN that was an effective therapeutic both in vitro and in vivo against APN-expressing prostate cancer models.
PubMed: 28465619
DOI: 10.1038/s41598-017-01542-5
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.2 Å)
Structure validation

227933

PDB entries from 2024-11-27

PDB statisticsPDBj update infoContact PDBjnumon